Explore more publications!

Healthy Living Maine: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Maine.

Press releases published on March 27, 2026

Preliminary Results for the Year Ended 31 December 2025
BiomX Inc. Received NYSE American Notification Letter Regarding Stockholders' Equity Deficiency
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Operational Highlights
Crescent Biopharma Announces Grants of Inducement Awards
Entera Bio Announces Full Year 2025 Financial Results and Provides Business Updates
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Cue Biopharma Announces CEO Transition
Second Fisher House Under Construction at the Pittsburgh VA
Monopar Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update
Colorectal Cancer Advocates Urge Congress to Fund New Research
Jushi Holdings Inc. Refinances Former 1st Lien Credit Facility and Former 2nd Lien Credit Facility with US$160 Million Non-Dilutive Debt Financing
LB Pharmaceuticals Presents New Analysis from the Phase 2 NOVA-1 Trial Highlighting LB-102’s Potential Impact on Cognitive Performance at the 2026 Annual Congress of the Schizophrenia International Research Society (SIRS)
Allsup Veterans Appeals Honors Vietnam War Veterans, Highlights Appeal and Dual-Benefit Options
Artelo Biosciences Announces $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
American Nurses Enterprise Releases Key Findings That Investing in Nursing Can Create Positive Financial Returns for Hospitals
Palvella Therapeutics Highlights Continued Progress Across Rare Skin Disease Pipeline with Two Poster Presentations at the 2026 American Academy of Dermatology Annual Meeting
Celldex Presents Positive Data from Phase 2 Chronic Spontaneous Urticaria and Phase 2 Cold Urticaria and Symptomatic Dermographism Studies Demonstrating Rapid, Profound and Durable Improvements in Patient Quality of Life at AAD 2026
AI Is Reshaping Neuroprotective Drug Discovery Market: New BCC Research Pulse Report Maps the Investment and Innovation Landscape
Results Presented at 2026 American Academy of Dermatology (AAD) Annual Meeting Provide Additional Support for the Therapeutic Potential of ATI-2138
First therapy funded by California taxpayer dollars is approved to treat rare childhood disorder

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions